Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines

Urologia Internationalis

Volumn 56, Issue 1, 1996, Pages 6-12

  Nouri, A M E ^a   Hussain, R F ^a   Dos Santo, A V L ^a   Oliver, R T D ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Adhesion molecules; Bladder tumours; Interferons; Major histocompatibility complex; Transfection

Indexed keywords

ALPHA INTERFERON; CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; BLADDER BIOPSY; BLADDER TUMOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR CELL LINE;

EID: 0030022918     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282799     Document Type: Article

References (25)

1. Oliver RTD: New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancer, Eur J Cancer 1991;27:1168-1172.
2. McMichacl AJ, Ting A, Zweerink HJ, Askonas BA: HLA-restriction of cell-mediated lysis of influenza virus-infected human cells, Nature 1977;311:750-752.
3. Naganuma H, Kiessling R, Patarroyo M, Hans-son M, Hantgretingcr R, Gronbcrg A: Increased susceptibility of IFN-y-treated neuroblastoma cells to lysis by lymphokine-activated cells: Participation of ICAM-1 induction on target cells, Int J Cancer 1991;47:527-532.
4. Johnson AR, Ziff M: Human gamma interferon increases the binding of T lymphocytes to endothelial cells, Clin Exp Immunol 1985:62: 554-560.
5. Johnson JP, Stadc BG, Holzmann B, Schwable W, RiethmUUer G: De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis, Proc Natl Acad Sci USA 1989:86:641-644.
6. Vanky F, Wang P, Patarroyo M, Klein E: Expression of the adhesion molecules 1CA, M-1 and major histocompatibility complex antigens on human tumour cells is required for their interaction with autologous lymphocytes in vitro, Cancer Immunol Immunother 1990:31: 19-27.
7. Malefyt RD, Verma S, Bejarano MT, Ranes-goldberg M, Hill M, Spits H: CD2/LFA-3 or LFA-l/ICAM-l but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic lymphocytes T, Eur J Immunol 1993:23:418-424.
8. Pandolfi F, Trentin L, Boyle LA, Stamcnkovic I, Byares R, Colvin RB, Kurnick JT: Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumour infiltrating lymphocytes, Cancer 1991:69:1163-1173.
9. Smith MEF, Marsh SGE, Bodmer JG, Gcls-thorpe K, Bodmer WF: Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen-3 in colorectal neoplasia, Proc Natl Acad Sci USA 1989:86:5557-5561.
10. Alberti S, Bernasconi S, Peri G, Jilek P, Ani-chini A, Parmiani G, Manlovani A: Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM-I defined by antibody blocking and gene transfer, Eur J Immunol 1992:22:2250- 2260.
11. Brosdsky FM, Paraham P, Branstable CJ, Crumpton MJ, Bodmer WF: Monoclonal antibodies for analysis of the HLA system, Immunol Rev 1979;47:3-61.
12. Lampson L, Levy R: Two populations of la molecules on a human B cell line, J Immunol 1980;125:293-299.
13. Krensky AM, Robbins E, Springer TA, Burkof T S J: LFAI, LFA2 and LFA3 antigens are involved in CTL-target conjugation, J Immunol 1984;132:2180-2182.
14. Nouri AME, Hussain RF, Dos Santos AVL, Mansour M, Oliver RTD: Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing, Br J Cancer 1993:67: 1223-1228.
15. lies RK, Oliver RTD, Kitau M, Walker C, Chard T: In vitro secretion of human chorionic gonadotrophin by bladder tumour cell lines, Br J Cancer 1987;55:623-640.
16. Boucraut R, Hakcm A, Fauchet R, Le Bouteil-ler P: Transfected trophoblast-dcrived human cells can express single HLA class I allelic product, Tissue Antigens 1991;37:84-89.
17. Rinke De Wit TF, Glazebrook J, Vloemans AA, Van den Elsen PJ, Ward J, Sutcliffe RC, Glazebrook J, Haworth A, Stern PL: Novel human MHC class I genes are expressed by tumour cell lines representing embryonic and extracmbryonic tissues, J Immunogenet 1989: 16:391-396.
18. Nouri AME, Smith MEF, Crosby D, Oliver RTD: Selective and non-selective loss of im-munoregulatory molecules (LILA-A, B, C antigens and LFA-3) in transitional cell carcinoma, Br J Cancer 1990:62:603-606.
19. Doussis IA, Kaklamanis L, Mortensen N, Harris AL, Gatter KC: Expression of adhesion molecules ICAM-1 and LFA-3 colorectal adenomas and carcinomas, Diagn Oncol 1992:2: 283-288.
20. Ree HJ, Khan AA, Elsakr M, Liau S, Tcplitz C: Intercellular adhesion molecule-1 (ICAM-1) staining of reactive and neoplastic follicles, Cancer 1992;71:2717-2822.
21. Kelly CP, Okcanc JC, Orellana J, Schroy PC, Yang S, lamont JT, Brady HR: Human colon cancer cells express ICAM-I in vivo and support LFA-1-dependent adhesion in vitro, Am J Physiol 1992:263:864.
22. Kelly SA, Gschmeissner S, East N, Balkwill FR: Enhancement of metastatic potential by y-interfcron, Cancer Res 1991:51:4020-4027.
23. Koyama S, Ebihara T, Fukao K: Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma, J Cancer Res Clin Oncol 1992:118:609-614.
24. Zarccone D, Viake O, Cerruti G, Tcnca C, Malorini W, Arancia G, Isoi F, Galandrini R, Velardi A, Moretta A, Grossi CE: Antibodies to adhesion molecules inhibit the lytic function of MHC-unrcstricted cytotoxic cells by preventing their activation, Cell Immunol 1992;143: 389-404.
25. Nabie GJ, Chang A, Nable NG, Plantz Gox BA, Huang L, Shu S: Immunotherapy of malignancy by in vivo gene transfer into tumours, Hum Gene Ther 1992:3:399-410